Page last updated: 2024-08-21

arsenic trioxide and Dyspnea

arsenic trioxide has been researched along with Dyspnea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, R; Fu, W; He, H; Hou, J1
Gnadler, M; Hecht, A; Lengfelder, E; Mezger, J1
Grimwade, D; Guidez, F; Mistry, AR; Solomon, E1
Hou, KZ; Jin, B; Liu, YP; Yu, P1
Camacho, LH; Chanel, S; Ellison, R; Heller, G; Ho, R; Scheinberg, DA; Soignet, SL; Warrell, RP1

Reviews

1 review(s) available for arsenic trioxide and Dyspnea

ArticleYear
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
    Cancer treatment and research, 2010, Volume: 145

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Dyspnea; Fever; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Models, Biological; Neoplasm, Residual; Oncogene Proteins, Fusion; Oxides; Transcription, Genetic; Treatment Outcome; Tretinoin

2010

Other Studies

4 other study(ies) available for arsenic trioxide and Dyspnea

ArticleYear
Arsenic trioxide induced rhabdomyolysis, a rare but severe side effect, in an APL patient: a case report.
    Frontiers of medicine, 2017, Volume: 11, Issue:2

    Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Creatinine; Dyspnea; Female; Humans; Leukemia, Promyelocytic, Acute; Medicine, Chinese Traditional; Oxides; Rhabdomyolysis

2017
[Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy].
    Deutsche medizinische Wochenschrift (1946), 2017, Volume: 142, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Hypotension; Leukemia, Promyelocytic, Acute; Leukocytosis; Lung Diseases; Oxides; Risk Factors; Severity of Illness Index; Syndrome; Treatment Outcome; Tretinoin

2017
Leukocytosis and retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2006, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Dyspnea; Female; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Leukocytosis; Male; Middle Aged; Oxides; Remission Induction; Syndrome

2006
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:13

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Dyspnea; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Oxides; Pleural Effusion; Syndrome; Tretinoin

2000